Diagnostics

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

A planned reverse merger for promising vaccine developer SVF Vaccines has collapsed after Nasdaq rejected the deal, leaving its lead investor scrambling.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

A new mobile app, Heart Works, launched for Rare Disease Day, offering a global community and powerful research tools for pulmonary hypertension patients.

A new animated video, voiced by a father and his daughter, offers hope and understanding to children battling a rare and life-threatening liver disease.

A new study links daily mango and avocado to better vascular function, but what does the science—and the funding—really tell us about this fruity fix?

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

Amidst industry-wide regulatory challenges, Meridian secures critical IVDR certification for its Alethia assays, ensuring continued market access in Europe.

Swiss biotech AC Immune begins a human trial for an oral drug aiming to halt the chronic inflammation driving diseases like Alzheimer's and Parkinson's.

A pivotal trial for a rare muscle disease failed its main goal, but promising data in a specific patient group offers a new, complex path forward.

Riding a wave of 41% Q4 revenue growth and nearing profitability, the diagnostics firm will showcase its lung cancer solutions at two major conferences.

Soar Autism Center launches a free, 40-hour RBT course focused on the play-based ESDM model, tackling workforce shortages and raising care standards.

CNO Financial Group honors its top volunteer and empowers associates to direct $190,000 to nonprofits, showcasing a powerful model of corporate giving.

A Korean firm says it can cure 34 diseases using cells from cloned embryos, walking a fine line between a medical breakthrough and a bioethical taboo.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.